Thoratec Company Profile (NASDAQ:THOR)

About Thoratec

Thoratec logoThoratec Corporation develops, manufactures and markets medical devices used for mechanical circulatory support for the treatment of heart failure patients. The Company's products include ventricular assist devices (VADs), such as HeartMate II Left Ventricular Assist System (HeartMate II), HeartMate III Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device (PVAD) and Thoratec Implantable Ventricular Assist Device (IVAD). For acute circulatory support, the Company's product lines are CentriMag Acute Circulatory System (CentriMag) and for pediatric patients PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). HeartMate III, a centrifugal-flow, chronic, left ventricular assist system.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: THOR
  • CUSIP: 88517530
Key Metrics:
  • Previous Close: $63.50
  • 50 Day Moving Average: $63.03
  • 200 Day Moving Average: $51.62
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 39.44
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to Thoratec:

Analyst Ratings

Consensus Ratings for Thoratec (NASDAQ:THOR) (?)
Ratings Breakdown: 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $47.25 (25.59% downside)

Analysts' Ratings History for Thoratec (NASDAQ:THOR)
DateFirmActionRatingPrice TargetDetails
12/3/2015JPMorgan Chase & Co.Reiterated RatingNeutral$36.00 -> $43.00View Rating Details
11/2/2015Leerink SwannBoost Price TargetOutperform$32.00 -> $45.00View Rating Details
11/2/2015Canaccord GenuityBoost Price TargetBuy$39.00 -> $41.00View Rating Details
10/14/2015Goldman Sachs Group Inc.UpgradeHoldView Rating Details
9/29/2015BMO Capital MarketsUpgradeMarket Perform -> Outperform$56.00 -> $60.00View Rating Details
9/25/2015BTIG ResearchReiterated RatingNeutralView Rating Details
8/24/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
7/23/2015Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details
7/22/2015Northland SecuritiesDowngradeOutperform -> Market Perform$55.00 -> $63.50View Rating Details
7/15/2015Oppenheimer Holdings Inc.Boost Price TargetOutperform$49.00 -> $52.00View Rating Details
5/8/2015Barclays PLCBoost Price TargetEqual Weight$40.00 -> $43.00View Rating Details
3/3/2015Credit Suisse Group AGSet Price TargetBuy$45.00View Rating Details
12/5/2014SunTrust Banks Inc.DowngradeBuy -> NeutralView Rating Details
11/6/2014Bank of America Corp.Reiterated RatingNeutral$29.00 -> $28.00View Rating Details
(Data available from 8/26/2014 forward)


Earnings History for Thoratec (NASDAQ:THOR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2015Q215$0.28$0.37$115.48 million$128.70 millionViewListenView Earnings Details
5/7/2015Q115$0.26$0.38$111.10 million$121.31 millionViewListenView Earnings Details
2/10/2015Q414$0.24$0.39$106.90 million$127.96 millionViewListenView Earnings Details
11/5/2014Q314$0.22$0.18$106.30 million$105.80 millionViewListenView Earnings Details
8/6/2014Q214$0.43$0.43$128.30 million$118.10 millionViewListenView Earnings Details
5/6/2014Q114$0.39$0.41$122.56 million$125.70 millionViewListenView Earnings Details
2/4/2014Q413$0.41$0.38$128.47 million$128.20 millionViewListenView Earnings Details
10/30/2013Q313$0.40$0.49$121.25 million$126.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.43$0.52$121.51 million$130.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.46$0.41$122.53 million$117.73 millionViewListenView Earnings Details
2/5/2013Q4 2012$0.38$0.38$119.09 million$128.50 millionViewListenView Earnings Details
11/1/2012Q312$0.39$0.41$111.80 million$117.80 millionViewN/AView Earnings Details
8/1/2012$0.45$0.45ViewN/AView Earnings Details
5/1/2012$0.41$0.61ViewN/AView Earnings Details
11/1/2011$0.33$0.41ViewN/AView Earnings Details
8/3/2011$0.35$0.44ViewN/AView Earnings Details
5/3/2011$0.33$0.34ViewN/AView Earnings Details
1/27/2011$0.30$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Thoratec (NASDAQ:THOR)
Current Year EPS Consensus Estimate: $1.37 EPS
Next Year EPS Consensus Estimate: $1.61 EPS


Dividend History for Thoratec (NASDAQ:THOR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Thoratec (NASDAQ:THOR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2015Neil F DimickDirectorSell8,173$44.98$367,621.54View SEC Filing  
5/15/2015Paul A LavioletteDirectorSell5,668$44.70$253,359.60View SEC Filing  
4/10/2015Neil F DimickDirectorSell4,786$43.00$205,798.00View SEC Filing  
12/4/2014J Daniel ColeDirectorSell5,000$31.83$159,150.00View SEC Filing  
5/27/2014Neil F DimickDirectorSell4,158$32.15$133,679.70View SEC Filing  
5/15/2014Paul LavioletteDirectorSell6,023$31.23$188,098.29View SEC Filing  
3/10/2014Gerhard BurbachCEOSell22,104$36.53$807,459.12View SEC Filing  
2/11/2014Gerhard BurbachCEOSell20,000$34.71$694,200.00View SEC Filing  
1/15/2014Gerhard BurbachCEOSell9,400$38.10$358,140.00View SEC Filing  
1/14/2014Gerhard BurbachCEOSell30,600$36.65$1,121,490.00View SEC Filing  
12/10/2013Gerhard BurbachCEOSell40,000$38.15$1,526,000.00View SEC Filing  
11/12/2013Gerhard BurbachCEOSell100,000$41.40$4,140,000.00View SEC Filing  
10/28/2013Gerhard F BurbachCEOSell15,000$40.02$600,300.00View SEC Filing  
10/17/2013Gerhard F BurbachCEOSell9,600$39.00$374,400.00View SEC Filing  
10/14/2013Gerhard BurbachCEOSell40,400$38.17$1,542,068.00View SEC Filing  
10/11/2013David Aaron LehmanSVPSell21,889$38.17$835,503.13View SEC Filing  
5/28/2013Neil F DimickDirectorSell1,273$31.58$40,201.34View SEC Filing  
5/20/2013Neil F DimickDirectorSell1,250$31.61$39,512.50View SEC Filing  
5/13/2013Neil F DimickDirectorSell1,250$33.93$42,412.50View SEC Filing  
11/26/2012Gerhard F BurbachCEOSell11,600$38.09$441,844.00View SEC Filing  
10/4/2012David Aaron LehmanSVPSell12,300$36.11$444,153.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Thoratec (NASDAQ:THOR)
DateHeadline logoVentricular Assist Device Market 2016 Review of MCS Industry With 2020 Forecasts (NASDAQ:THOR) - August 24 at 7:33 PM
News IconResearch report explores the global cardiac equipment market 2016: industry demand, segment, statistics and research to 2022 (NASDAQ:THOR) - August 23 at 12:16 PM
News IconGlobal Cardiac Equipment Market 2016: Industry Demand, Segment, Statistics and Research to 2022 (NASDAQ:THOR) - August 23 at 12:16 PM
News IconArtificial Organs Market : Segmentation, Industry trends and Developments 2021 (NASDAQ:THOR) - August 17 at 10:45 AM logoGlobal Cardiac Equipment Market 2016: Industry Review, Research, Statistics, and Growth to 2022 (NASDAQ:THOR) - August 16 at 7:53 PM
News IconCardiac Assist Devices Market Strategies and Forecasts, 2015-2025 (NASDAQ:THOR) - August 14 at 9:49 AM logoThoratec Corporation - Medical Equipment - Deals and Alliances Profile - New Market Research Report (NASDAQ:THOR) - August 14 at 9:49 AM
News IconWorldwide Cardiac Surgery Devices Market: Value Chain and Key Players (2016 - 2026) (NASDAQ:THOR) - August 12 at 7:57 PM logoGlobal Artificial Organ Bank Market to be Hampered by High Prices of Artificial Organs (NASDAQ:THOR) - August 10 at 8:20 PM
News IconLiraglutide does not improve clinical stability after hospitalization for HFrEF (NASDAQ:THOR) - August 4 at 8:15 PM logoResearch report covers the Cardiac Assist Devices Market share and Growth, 2015-2025 (NASDAQ:THOR) - August 4 at 11:00 AM
News IconMarket Forecast Report on Cardiac Assist Devices, 2015-2025 (NASDAQ:THOR) - July 30 at 10:32 AM
News IconCanada Cardiovascular Devices Market Research And Outlook To 2020 (NASDAQ:THOR) - July 26 at 8:16 PM
News IconMedtronic in $1.1bn deal to buy HeartWare (NASDAQ:THOR) - June 28 at 10:16 AM
News IconMedical device maker Medtronic to buy HeartWare for $1.1B (NASDAQ:THOR) - June 27 at 7:39 PM
News IconCardiac Equipment Industry Sales, Supply and Consumption 2016 Analysis and Forecasts to 2020 (NASDAQ:THOR) - June 21 at 7:16 PM logoCardiac Surgery Devices Market: Global Industry Analysis and Forecast 2016 - 2026 (NASDAQ:THOR) - June 19 at 9:49 AM logoGermany Cardiovascular Devices Market Outlook to 2021 - New Market Research Report (NASDAQ:THOR) - June 1 at 8:30 PM logoNew Study: Asia-Pacific Cardiac Assist Devices Market Outlook to 2021 (NASDAQ:THOR) - May 28 at 3:44 AM
News IconCalifornia Life Sciences Association Elects Leaders from Merck, Organovo and St. Jude Medical to its Board of Directors (NASDAQ:THOR) - May 25 at 11:39 AM logoNew Study: Italy Cardiac Assist Devices Market Outlook to 2021 (NASDAQ:THOR) - May 25 at 11:39 AM
News IconEU5's cardiac assist devices market share to 2021 made available by top research firm (NASDAQ:THOR) - May 17 at 12:30 PM logo2021 United States Cardiovascular Devices Market Analysis and Forecast (NASDAQ:THOR) - May 16 at 9:25 PM
News IconAsia-Pacific Cardiac Assist Devices Market Share,Supply and Consumption 2016 to 2021 Market Research Report (NASDAQ:THOR) - May 14 at 2:50 AM
News IconMechanical Circulatory Support in the New Era: An Overview (NASDAQ:THOR) - May 13 at 5:13 AM logoCardiac Assist Devices Market Dynamics, Forecast, Analysis and Supply Demand 2015-2025 (NASDAQ:THOR) - May 13 at 5:13 AM logoBrazil Cardiac Assist Devices Market Outlook to 2021 Fundamental Concepts and Current Research (NASDAQ:THOR) - May 12 at 6:16 AM logoChina Cardiac Assist Devices Market Outlook to 2021 Overview, Shares, Size and Forecast Report (NASDAQ:THOR) - May 10 at 10:19 PM
News IconCardiac Assist Devices Market in France Analysis for 2021 (NASDAQ:THOR) - May 10 at 10:19 PM
News IconSouth Korea Cardiac Assist Devices Market to 2021 – Analysis of Thoratec Corporation, Maquet Holding B.V. & Co. KG and Others (NASDAQ:THOR) - May 9 at 10:41 PM
News IconRecent research: 2021 Germany cardiac assist devices market research outlook (NASDAQ:THOR) - May 7 at 8:09 PM
News IconAbbott Laboratories acquires St. Jude Medical in $25B deal (NASDAQ:THOR) - May 6 at 6:10 AM
News IconAbbott Boosts Cardio Device Business With $25 Billion St. Jude Buy (NASDAQ:THOR) - May 5 at 2:37 AM
News IconNewly released market study: United Kingdom Cardiac Assist Devices Market Outlook to 2021 (NASDAQ:THOR) - May 5 at 2:37 AM
News IconAbbott agrees to buy St Jude Medical for US$25bil (NASDAQ:THOR) - May 2 at 3:00 AM
News IconDeal Watch: A Pharmaceutical Frenzy for a Half-Dozen Firms (NASDAQ:THOR) - April 29 at 10:45 PM logoMoody's reviews St. Jude Medical's Baa2 rating for downgrade (NASDAQ:THOR) - April 29 at 6:17 AM
News IconResearch details developments in the United States cardiac assist devices market for 2021 (NASDAQ:THOR) - April 27 at 11:08 PM logo2021 United States Cardiac Assist Devices Market Analysis and Forecast (NASDAQ:THOR) - April 26 at 6:14 AM
News IconUnited States Cardiac Assist Devices Market Outlook Analysis to 2016 & Forecast to 2021 (NASDAQ:THOR) - April 23 at 3:52 AM logoThoratec Acquisition: The Impact on St. Jude’s Growth Potential (NASDAQ:THOR) - April 21 at 11:06 AM logoHow Big Is the St. Jude Medical Threat to Abiomed, Inc. Stock? (NASDAQ:THOR) - April 19 at 9:42 AM logoNew Market Report: Thoratec Corporation (THOR) - Medical Equipment - Deals and Alliances Profile (NASDAQ:THOR) - April 6 at 11:17 AM logoFuture Trends in Artificial Vital Organs and Medical Bionics Market with Analysis by 2018 (NASDAQ:THOR) - April 1 at 10:33 PM
News IconProcyrion Appoints New Board Member (NASDAQ:THOR) - March 23 at 10:28 PM
News IconArtificial Organ And Bionics Market Trends, Company Share To 2020: Grand View Research, Inc. (NASDAQ:THOR) - March 15 at 10:29 AM logoGlobal Artificial Organs and Medical Bionics Market to Register a CAGR of 9.20% from 2012 to 2018 Due to Increasing Demand for Organ Transplantation (NASDAQ:THOR) - March 11 at 10:19 PM
News IconArtificial Organs Market: Segments, Dynamics, Size, Forecast , Supply & Demand Value Chain, Current Issues and Forecast to 2015 to 2021 (NASDAQ:THOR) - March 4 at 12:49 PM logoCodexis Adds Life Sciences Industry Veteran David V. Smith To Its Board Of Directors (NASDAQ:THOR) - March 3 at 12:52 PM logoDigiSight Technologies Expands Senior Management Team To Support Paxos™ Mobile Health Platform Launch And Future Development (NASDAQ:THOR) - March 2 at 12:42 PM


Thoratec (NASDAQ:THOR) Chart for Friday, August, 26, 2016

Last Updated on 8/26/2016 by Staff